Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2003-11-17
2010-06-22
Mosher, Mary E (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C424S218100, C424S232100
Reexamination Certificate
active
07740863
ABSTRACT:
An immunogenic or vaccine composition to induce an immune response or protective immune response against West Nile virus (WNV) in an animal susceptible to WNV. The composition includes a pharmaceutically or veterinarily acceptable vehicle or excipient, and a vector. The vector contains heterologous nucleic acid molecule(s), expresses in vivo in the animal WNV antigen, immunogen or epitope thereof, e.g., WNV E; WNV prM and E; WNV M and E; WNV prM, WNV M and E, WNV polyprotein prM-E, WNV polyprotein M-E, or WNV polyprotein prM-M-E. The composition can contain an adjuvant, such as carbomer. Methods for making and using such a composition, including prime-boost regimes and including as to differential diagnosis, are also contemplated.
REFERENCES:
patent: 5338683 (1994-08-01), Paoletti
patent: 5505941 (1996-04-01), Paoletti
patent: 5744141 (1998-04-01), Paoletti et al.
patent: 5756103 (1998-05-01), Paoletti et al.
patent: 6713068 (2004-03-01), Audonnet et al.
patent: 7227011 (2007-06-01), Chang
patent: 2003/0022849 (2003-01-01), Chang
patent: WO 99/44633 (1999-09-01), None
patent: WO 01/60847 (2001-08-01), None
Yamshikov et al (Gene 149:193-201).
Ramshaw et al (Immunology Today 21:163-165, 2000).
Paoletti (Proc Natl Acad Sci USA, 1996, 93:11349-11353).
Goverdhan et al. (Acta Virol, 1992, 36: 277-283).
Ostlund et al. (Vet Clin North Am Equine Pract, 2000, 16: 427-41, Abstract).
Stocks et al. (J Virol, 1998, 72: 2141-2149).
Chang et al. (J Virol, 2000, 74: 4244-4252).
Mumford et al. (Epidemiol Infect, 1994, 112: 421-437, Abstract).
Varga et al. (Veterinary Microbiol, 1997, 56: 205-212).
Ruitengerg et al. (Vaccine, 2000, 18:1367-1373).
Siger et al (Veterinary Therapy 7:249-256, 2006).
Audonnet Jean-Christophe Francis
Loosmore Sheena May
Minke Jules Maarten
Jarecki-Black Judy
Kowalski, Esq. Thomas
Merial
Merial Limited
Mosher Mary E
LandOfFree
Recombinant vaccine against West Nile Virus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant vaccine against West Nile Virus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant vaccine against West Nile Virus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4175371